Device Identity and Digital Claims: US–China Governance in 2026
Keep US and China device identifiers, intended-use evidence and digital advertising approvals aligned through a controlled product and claims record.
Expert insights on AI visibility, SEO strategy, and growth tactics for life sciences companies.
Focused articles on AI visibility, SEO, and sustainable growth for life sciences companies.
Keep US and China device identifiers, intended-use evidence and digital advertising approvals aligned through a controlled product and claims record.
Get the latest insights on AI visibility and life sciences marketing delivered to your inbox.
No spam. Unsubscribe anytime.
Align FDA correction and removal reporting, consignee notices, public warnings and Early Alerts with a documented website publishing handoff.
Audit 64 research artifacts and 188 brand snapshots to plan useful MedTech content, maintain its evidence and measure search, citations and qualified demand.
Audit FDA status wording across device pathways, websites, press releases and AI answers, with a practical claims matrix and clearly bounded evidence.
An 188-domain audit tests crawler policies, page access and metadata, then turns bounded source panels into a practical MedTech website release checklist.
A 40-market evidence model turns trade, access, language, digital readiness, and delivery constraints into a practical website localization sequence.
We analyzed 40 capped AI recommendation panels, 1,689 citations, and 188 brand reports to show what an AI shortlist does—and does not—measure.
We measured how often the 160 largest FDA-registered medtech brands get cited by ChatGPT and Google AI. The result is a winner-take-most gap — and a clear GEO playbook.
68% of procurement teams now use AI for vendor research. Learn how Generative Engine Optimization (GEO) determines which medical devices get recommended.